Job Information
J&J Family of Companies Associate Director, Global Associate Compound Market Access Leader, Oncology in Raritan, New Jersey
Associate Director, Global Associate Compound Market Access Leader, Oncology - 2406170021W
Description
Janssen Global Commercial Strategy Organization, a group within Janssen Global Services and a member of Johnson & Johnson's family of companies, is recruiting for a Global Compound Market Access Leader.
At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found.
Janssen Global Services, LLC encompasses groups that provide leadership across critical business areas for Janssen including, Global Commercial Strategy Organization; Global Pharmaceuticals Communication and Public Affairs; U.S. Pharmaceuticals Procurement Group; and Pharmaceuticals Group Business Development.
The Associate CMAL, reporting to the Compound Market Access Leaders (CMAL), has a key leadership role in developing and driving the market access strategy for the respective product/indication, aligned with the global brand strategy. In doing so, the Assoc. CMAL will shape key strategic decisions such as clinical development and integrated evidence generation plans to ensure that strategic plans fully meet the needs of market access in key countries. The Assoc. CMAL takes a lead in development of brand value propositions and collaborates through the Compound and Extended Market Access Teams (CMAT / EMAT) to deliver timely, optimal reimbursement in a highly challenging environment across diverse regions with complex and differing needs. The Assoc. CMAL must understand the needs of markets and develop appropriate solutions.
Key Responsibilities:
Support the Compound Market Access Leader (CMAL) for strategic planning and implementation of the payer value generation and access strategies for the product / indication in scope.
Drive the design and management of health outcomes studies for the indication including: systematic literature reviews, real world evidence studies, and user-friendly cost effectiveness and budget impact models that can be adapted for coordinated delivery to key decision makers.
Interact with Regional Market Access/Health Economics / Outcomes Research and Medical Affairs teams to coordinate and develop real world evidence generation in support of their access programs.
Provide leadership to the indication specific clinical working group (CWG) in terms of market access data needs related to the clinical development plan.
Act as part of cross-functional Global Indication Team with Global Commercial & Medical Affairs and ensure appropriate evidence is generated to develop robust differentiable value proposition for the indication at launch and during life cycle management.
Foster collaboration and seamless working with Global and regional HEMAR partners as well as functions in Global Market Access HUB including PRO, Modeling, RWE and Analytics; making sure that priorities are jointly agreed so that deliverables are agreed, and expectations managed.
Take indication specific budgetary responsibility, ensuring that spending is managed effectively throughout the year and to plan.
Keep up to date with scientific developments, bringing the latest techniques and analyses to build the strongest possible value proposition.
Understand the patient perspective of the disease and recommend strategies that can support the patient voice in key payer negotiations.
Qualifications
Education:
- Must have a minimum of a master’s degree in appropriate field (Science, Economics, Biostatistics, Epidemiology, Health Economics, or Public Health) or a PharmD
Required skills and experience:
Strong business acumen with ability to think strategically.
A minimum of 6 years in Health Economics and Outcomes Research or Market Access.
A thorough understanding of pharmaceutical commercialization and drug development process.
Deep understanding of Health Economics, meta-analyses, retrospective and prospective data generation activities, clinical trial methodologies, relative effectiveness and all other ingredients of an optimal value proposition and professional HTA or price & reimbursement submissions.
Deep appreciation of science and ability to translate scientific information into strategy.
An ability to manage multiple demands and priorities on time, influence without authority, gain alignment and drive decision making.
The successful candidate will have superior communication and strong interpersonal skill, demonstrated through working within cross-functional teams.
A strong understanding of and/or experience with the reimbursement environment for key international markets is required.
Excellent communication and leadership skills are a must with a strong track record of producing results in a matrix-based environment
This position is based in Raritan, NJ and may require up to 30% domestic and/or international travel
Preferred skills and experience:
Prior oncology experience
Demonstrated leadership ability to successfully work across functional and geographic boundaries, preferably across multiple countries/market types/access models
The anticipated target compensation for this role is $135,000-$232,300
Johnson.& Johnson Family of Companies are equal opportunity employers, and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, genetic information, national origin, protected veteran status, disability status, or any other characteristic protected by law.
Primary Location NA-US-New Jersey-Raritan
Organization Janssen Global Services, LLC (6085)
Job Function Health Economics Market Access
Req ID: 2406170021W